Cognita Imaging will build and test its evaluation framework on 1 million patient exams from a large United States cohort to analyze performance across diverse patient groups and equipment.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

FDA approvals, clinical trial design, psychedelic drug policy, compounding pharmacy regulation, and drug scheduling.

AI research advances and the benchmarks used to measure progress.